(Q39064254)

8 September 2017

title

Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells (English)

1 reference

8 September 2017

1 reference

7

0 references

author name string

Meiying Li

1

1 reference

8 September 2017

Xuejun Yu

2

1 reference

8 September 2017

Hui Guo

3

1 reference

8 September 2017

Limei Sun

4

1 reference

8 September 2017

Aijun Wang

5

1 reference

8 September 2017

Qiji Liu

6

1 reference

8 September 2017

Jisheng Li

8

1 reference

8 September 2017

publication date

12 November 2013

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

2461-2471

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1326-6

8 September 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Current diagnosis and treatment of pancreatic cancer in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Bufalin induces the apoptosis of acute promyelocytic leukemia cells via the downregulation of survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

On the role of Hsp27 in regulating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Neferine, an alkaloid ingredient in lotus seed embryo, inhibits proliferation of human osteosarcoma cells by promoting p38 MAPK-mediated p21 stabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Cardiac glycosides block cancer growth through HIF-1α- and NF-κB-mediated Plk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

HSP27 and HSP70: potentially oncogenic apoptosis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Heat Shock Protein 27 Controls Apoptosis by Regulating Akt Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Multiple functions of BCL-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

The cell cycle and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Targeting the S and G2 checkpoint to treat cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Cell-cycle checkpoints and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1326-6

Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells

21 January 2018

1 reference

12 December 2020

Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells

1 reference

12 December 2020

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale

1 reference

12 December 2020

Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis

1 reference

12 December 2020

Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells

1 reference

12 December 2020

Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma

1 reference

12 December 2020

Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research

1 reference

12 December 2020

A proteomic profiling of gemcitabine resistance in pancreatic cancer cell lines.

1 reference

12 December 2020

HSP27 inhibits cytochrome c-dependent activation of procaspase-9.

1 reference

12 December 2020

Triggering apoptotic death of human malignant melanoma a375.s2 cells by bufalin: involvement of caspase cascade-dependent and independent mitochondrial signaling pathways

1 reference

12 December 2020

Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia

1 reference

12 December 2020

Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses

1 reference

12 December 2020

OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer

1 reference

12 December 2020

KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

10.1007/S13277-013-1326-6

Identifiers

DOI

1 reference

8 September 2017

1 reference